Additional file 1 of Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study

article OA: green CC0
AI-generated summary by claude@2026-06, 2026-06-07

This study evaluated the efficacy and safety of eliapixant for endometriosis-associated pelvic pain in a randomized, placebo-controlled phase 2b trial.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Supplementary Material 1

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Source provenance

openalex
last seen: 2026-05-11T08:53:43.914613+00:00
License: CC0 · commercial use OK